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Munc13-1 Is a Presynaptic Phorbol Ester Receptor
that Enhances Neurotransmitter Release
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fluence on neurotransmitter release by modifying ion
channels and changing the ionic conductance of nerve
cell membranes and/or by acting directly on the trans-Summary
mitter release apparatus (Dekker et al., 1991; Byrne and
Kandel, 1996; Gillis et al., 1996). Apart from Ca21, whichMunc13-1, a mammalian homolog of C. elegans unc-
stimulates a subset of PKC isoforms, most PKCs are13p, is thought to be involved in the regulation of synap-
activated by diacylglycerol and, more potently, by thetic transmission. We now demonstrate that Munc13-1
tumor-promoting phorbol esters (Newton, 1995, 1997).is a presynaptic high-affinity phorbol ester and diacyl-
Both types of ligands bind to the regulatory C1-domainglycerol receptor with ligand affinities similar to those
of PKCs and serve as hydrophobic anchors that recruitof protein kinase C. Munc13-1 associates with the
the enzyme to the plasma membrane, stabilize its activeplasma membrane in response to phorbol ester bind-
conformation, and increase its susceptibility to othering and acts as a phorbol ester±dependent enhancer
second messengers (Newton, 1995, 1997). As a conse-of transmitter release when overexpressed presynap-
quence, phorbol esters were used as key reagents in atically in the Xenopus neuromuscular junction. These
large number of studies examining the role of PKC in
observations establish Munc13-1 as a novel presynap-
transmitter release and many other physiological pro-
tic target of the diacylglycerol second messenger
cesses. Almost invariably, their effects were attributed
pathway that acts in parallel with protein kinase C to to PKC activation. However, phorbol esters also mediate
regulate neurotransmitter secretion. PKC-independent effects on membrane traffic (Fabbri
et al., 1994) and synaptic transmission (Scholfield and
Introduction
Smith, 1989; Redman et al., 1997), indicating the pres-
ence of additional diacylglycerol and phorbol ester tar-
Transmitter release from nerve cells is mediated by exo- gets involved in neuronal membrane traffic.
cytosis. Synaptic vesicles, the key organelles in this The family of unc-13p-like proteins constitutes a group
process, undergo a complex cycle of fusion and fission of novel potential phorbol ester and diacylglycerol re-
events that regulate the release process in the synapse. ceptors that may be involved in synaptic signaling
Vesicles are generated by budding from early endo- (Maruyama and Brenner, 1991; Brose et al., 1995; Betz
somes and are loaded with neurotransmitter. After a et al., 1997). Caenorhabditis elegans unc-13p has an
translocation process, they dock at the active zone and essential function in synaptic transmission: mutations in
mature to a fusion competent state. In response to a the unc-13 locus lead to a severely paralyzed phenotype
rise in the intracellular calcium concentration, fusion that was interpreted to reflect a perturbation of presyn-
competent vesicles release their content through exo- aptic processes (Hosono et al., 1987; Hosono and Kam-
cytosis. Vesicular protein and membrane components iya, 1991). The primary structure of unc-13p is character-
ized by twoC2-domains homologous to theCa21-binding
regulatory region of PKCs and a zinc finger±like C1-‖ To whom correspondence should be addressed (e-mail: brose@
domain that binds phorbol esters with high affinity (Ka-mail.mpiem.gwdg.de).
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Figure 1. Munc13-1 Immunoreactivity in the
Hippocampus
(A) Low-power view of the layer-specific dis-
tribution. L, stratum lucidum; O, stratum or-
iens; R, stratum radiatum; LM, stratum lacu-
nosum-moleculare; M, molecular layer of
dentate gyrus; H, Hilus of dentate gyrus.
Arrow head, hippocampal fissure; arrows,
border between inner and outer two-thirds of
the molecular layer. Scale bar, 1 mm.
(B) In region CA3, the pyramidal cell layer (P)
is unstained whereas the stratum lucidum (L)
shows intensely stained patches of the same
size and distribution as mossy fiber terminals.
Scale bar, 50 mm.
(C) In region CA1, the cell bodies in the pyra-
midal cell layer (P) are unstained. In the stra-
tum radiatum, there is a punctate pattern sug-
gestive of presynaptic elements lining the
surface ofdendrites (arrows). Scale bar, 50 mm.
(D) A mossy fiber terminal (star) in stratum
lucidum shows heterogeneous distribution of
reaction product that appears densest close
to the presynaptic membrane. Arrowheads
point to active zones from the dendritic side.
Scale bar, 0.5 mm.
(E) Numerous Munc13-1-positive small axon
terminals in stratum radiatum of region CA1,
same symbols as in (D). Scale bar, 0.5 mm.
isoforms, Munc13-2 and Munc13-3, are brain-specific target that represents a second messenger pathway
alternative to PKC.mammalian homologs of the C. elegans unc-13 gene
product (Brose et al., 1995). Like their nematode coun-
terpart, Munc13s are thought to regulate synaptic func- Results
tion. Munc13-1 interacts with syntaxin 1, an essential
component of the synaptic release machinery involved Localization of Munc13-1 in Rat Brain
All Munc13 isoforms are expressed in a brain-specificin vesicle maturation and fusion (Betz et al., 1997), and
with DOC2, a putative regulator of transmitter secretion manner (Brose et al., 1995). However, their subcellu-
lar localization, or that of their C. elegans counterpart(Orita et al., 1997). Beyond such fragmentary circum-
stantial evidence, the functional role of Munc13s (or that unc-13p, is not known. As morphological data on the
localization of Munc13s are essential for further func-of unc-13p) in synaptic physiology is not known.
In the present study, we provide direct evidence for tional analysis, we studied the distribution of Munc13-1
in rat brain. For that purpose, a novel monoclonal anti-an involvement of Munc13-1 in presynaptic signaling.
Our findings characterize Munc13-1 as a high-affinity body to Munc13-1 (clone 3H5) was generated and used
in a detailed immunocytochemical analysis of rat hippo-phorbol ester receptor that is specifically localized to
presynaptic transmitter release sites. Phorbol ester bind- campus and cortex.
In hippocampus, a distinct layering of Munc13-1 im-ing leads to the translocation of all Munc13 isoforms to
the plasma membrane of transfected fibroblasts. Upon munostaining was observed. While layers containing py-
ramidal and granule cell bodies were devoid of signal,presynaptic overexpression in Xenopus laevis neuro-
muscular junctions, Munc13-1 acts as a phorbol ester± the degree of staining in the neuropil coincided with the
layered distribution of termination areas of the differentdependent enhancerof spontaneous and evoked neuro-
transmitter release. Our data establish Munc13-1 as an hippocampal axon systems (Figure 1A). Strongest sig-
nals were detectable in regions of highest presynapticimportant presynaptic phorbol ester and diacylglycerol
Role of Munc13-1 in Transmitter Release
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Figure 2. Munc13-1 Immunoreactivity in the
Parietal Cortex
(A) A rather homogenous and dense labeling
is found throughout laminae I to VI. The white
matter (WM) is sparsely stained. Scale bar,
250 mm.
(B) Electron micrograph of a region with many
Munc13-1-positive synapses (stars). Arrow-
headspoint to active zones from the dendritic
side. Scale bar, 0.5 mm.
(C) Two adjacent axo-spine synapses. One is
formed by a Munc13-1-positive axon terminal
(white star) and the other by a negative one
(open star). Arrowheads point to active zones
from the dendritic side. Scale bar, 0.5 mm.
(D) Munc13-1-positive material (arrow) be-
neath the plasma membrane of a dendrite
that is postsynaptic to a Munc13-1-negative
axon terminal (open star). Arrowheads point
to active zones from the dendritic side. Scale
bar as in C.
terminal density. In particular, strong patchy staining of Phorbol Ester Binding to Munc13-1
Our immunocytochemical analysis strongly suggestedmossy fiber terminals in stratum lucidum (Figure 1B) and
punctate staining of presynaptic terminals in stratum a presynaptic function of Munc13-1. In view of the possi-
bility that unc-13p-like proteins might indeed serve asradiatum (Figure 1C) were observed. Electron micro-
scopic analysis demonstrated that most presynaptic presynaptic diacylglycerol and phorbol ester receptors,
we analyzed phorbol ester binding to Munc13-1 usingboutons in the stratum radiatum were strongly stained
(Figure 1E), whereas very little or no labeling of dendrites a recombinant bacterial fusion protein encoding gluta-
thione-S-transferase (GST) in frame with the Munc13-1or dendritic spines was apparent. Likewise, all mossy
fiber terminals in the stratum lucidum contained high C1-domain (Munc13-1C1WT; Figure 3A). The C1-domain
contains a Cys6His2 motif that forms a zinc finger struc-amounts of Munc13-1 immunoreactivity that was con-
centrated at presynaptic release sites adjacent to post- ture (Hommel et al., 1994) and is responsible for phorbol
ester binding in PKCs. The first His residue in thesynaptic densities (Figure 1D).
Like in the hippocampus, a prominent and dense pun- Cys6His2 motif (corresponding to His-567 in Munc13-1)
is essential for phorbol ester binding in PKCs (Hommelctate labeling in the neuropil, along with unstained pyra-
midal cell bodies in all cortical layers, indicated a pre- et al., 1994; Quest et al., 1994).
Munc13-1C1WT bound the protein kinase C activatordominantly presynaptic localization of Munc13-1 in the
cerebral cortex (Figure 2A). This was confirmed under [3H]4b-phorbol-12,13-dibutyrate ([3H]4b-PDBu) with high
specificity, while GST alone did not bind. Mutation ofthe electron microscope (Figures 2B and 2C). Compared
to the hippocampus, the cortex contained a larger num- His-567 to Lys in the Cys6His2 motif of the C1-domain
abolished this binding (Munc13-1C1H567K; Figures 3B andber of Munc13-1-negative synapses (Figure 2C). Quanti-
fication of immunostained synapses in randomly chosen 4A), indicating that the integrity of the zinc finger domain
is essential for phorbol ester binding. The affinity of themicrographs demonstrated that only 45% of synapses
in the parietal cortex are Munc13-1-positive (in contrast Munc13-1 C1-domain for [3H]4b-PDBu was found to be
similar to that of PKC (KD 5 5 nM; Figures 4B and 4C).to 96% in the stratum lucidum and 56% in the stratum
radiatum of the hippocampus). As a distinct cortical Likewise, the pharmacological characteristics of phor-
bol ester binding to the Munc13-1 C1-domain closelyspecialty, spots of Munc13-1 immunoreactivity were oc-
casionally detected in apical dendrites of pyramidal resembled those observed in PKC. Binding was inhib-
ited by the putative endogenous ligand diacylglycerolcells where the reaction product was mostly confined
to the vicinity of vesicular structures (Figure 2D). This (Figure 4D), by 4b phorbol esters like 4b-PDBu and
4b-12-O-tetradecanoylphorbol-13-acetate (4b-TPA), anddendritic labeling contributed less than 10% to the over-
all Munc13-1 immunoreactivity in the cortical neuropil, by calphostin C, which all bind to the C1-domain of PKCs
as well. In addition, the rather nonspecific PKC inhibitoras estimated from randomly chosen electron micro-
graphs, while essentially all other stained structures re- polymyxin B inhibited phorbol ester binding to Munc13-1.
In contrast, commonly used control reagents that dosembled presynaptic terminals.
In all brain regions, staining was abolished after pre- not activate PKC (the 4a phorbol esters 4a-PDBu and
4a-TPA), and reagents that bind to the ATP bindingadsorption of the antibody to a Sepharose column cou-
pled with the antigen used for immunization (data not site of PKC (bisindolylmaleimide), did not inhibit phorbol
ester binding to the Munc13-1 C1-domain (Figure 4E;shown).
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Figure 3. Munc13 Domain Structures and
Expression Constructs
(A) Domain structures of full-length Munc13-1,
Munc13-2, and Munc13-3, and representa-
tion of Munc13-1 fragments used for expres-
sion constructs. GFP, green fluorescent pro-
tein; GST, glutathione-S-transferase.
(B) Core Cys6His2 zinc finger motif of the
Munc13-1 C1-domain. Cys and His residues
forming the zinc finger are indicated by open
circles. WT, wild-type; H567K, mutation His-
567 to Lys (indicated by arrow); a, a-helical
region; b, b-strand region.
see Gordge and Ryves, 1994, for a review on PKC inhibi- sufficient to mediate phorbol ester±dependent translo-
cation in Munc13-1, as demonstrated by the redistribu-tors and their specificity).
tion of a Munc13-1 C1-domain construct (Munc13-1C1WT)
in response to 4b-TPA (Figure 6).
Phorbol Ester-Dependent Translocation
of Munc13 Isoforms
Phorbol esters activate PKC by recruiting the enzyme Role of Munc13-1 in Synaptic Transmission
Our morphological, biochemical, and cell biologicalto the plasma membrane (Newton, 1995, 1997; Sakai et
al., 1997). To assay whether a similar phorbol ester- analyses established Munc13-1 as a presynaptic high-
affinity diacylglycerol and phorbol ester receptor. Todependent translocationand activation of Munc13 takes
place in a cellular environment, we studied the redistri- evaluate a possible contribution of Munc13-1 to the di-
acylglycerol- or phorbol ester±dependent modulation ofbution of transiently expressed Munc13 constructs in
response to phorbol esters in a human fibroblast cell presynaptic efficacy, we examined the consequences
of Munc13-1 overexpression in Xenopus neuromuscularline (HEK293). For that purpose, we generated a series
of mammalian expression constructs that encode fusion junctions.
For that purpose, we injected mRNA encoding full-proteins of full-length Munc13-1, 22, or 23 with C-termi-
nally attached green fluorescent protein (GFP; Figure length Munc13-1WT or Munc13-1H567K (which carries the
His-567 to Lys mutation and does not bind phorbol es-3A). HEK293 cells were transfected with these con-
structs and challenged with 100 nM 4b-TPA. We found ters) together with GFP mRNA into early blastomeres of
Xenopus and studied synaptic transmission in nerve-that all three wild-type Munc13 isoforms translocated
to the plasma membrane in response to 4b-TPA (Figure muscle cocultures prepared from the neural tube and
associated myotomal tissue of injected stage 20±22 em-5). In contrast, full-length Munc13-1H567K (which carries
the His-567Lys mutation and does not bind phorbol es- bryos. In each case, identical heterologous expression
levels of Munc13-1WT and Munc13-1H567K were verifiedters) was insensitive to 4b-TPA (Figure 5), indicating
that phorbol esters mediate the translocation of Munc13 by Western blotting of individual injected and uninjected
embryos from batches that were also used for cocultureproteins in a PKC-independent manner by binding to
the Munc13 C1-domains. preparations (data not shown). Trains of six action po-
tentials were elicited every 2±4 seconds in nerve cellsTo determine the minimal sequence of Munc13-1 that
is required to mediate translocation, we expressed GFP by extracellular stimulation with a monopolar electrode
or by current injection through the patch pipette in thefusion proteins of Munc13-1 fragments (Figure 3A). As
translocation of PKC is dependent on both the C1- current clamp mode. The resulting evoked postsynaptic
currents (EPSCs) were recorded from the innervateddomain and the C2-domain, we first tested the phorbol
ester±induced redistributionof the C1/C2 tandem domain muscle cells in the whole-cell configuration. After about
100 sec, 200 nM 4b-TPA was applied locally for 60 secof Munc13-1 (Munc13-1C1/C2WT) and found that it trans-
located to the plasma membrane after stimulation with onto the area of nerve-muscle contact.
In a typical uninjected cell (Figure 7A), theEPSC ampli-4b-TPA, whereas the distribution of the corresponding
His-567Lys mutation (Munc13-1C1/C2H567K) was unaf- tude increased sharply approximately 20 sec after the
start of 4b-TPA application and reached its maximumfected (Figure 6). In contrast, translocation of Munc13-
1C1/C2WT as well as full-length Munc13-1WT was not in- after about 30 sec. Averaging the EPSC amplitude be-
fore and after application of 4b-TPA revealed an in-duced by Ca21 ionophores (data not shown), supporting
previous biochemical findings (Brose et al., 1995) and crease in the absolute EPSC amplitudes from 5.7 6 1.8
nA to 8.5 6 1.2 nA (mean 6 s.d.), which corresponds to aindicating that, unlike PKC, the C2-domain of Munc13-1
does not induce Ca21-dependent membrane associa- 48% increase in relative synaptic transmission following
phorbol ester application. Analysis of 19 noninjectedtion. Rather, a single copy of a C1-domain zinc finger is
Role of Munc13-1 in Transmitter Release
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cells demonstrated an average EPSC amplitude in-
crease of 44.6 6 4.5% (mean 6 s.e.m.) after 4b-TPA
application.
When the same protocol was applied to neuromuscu-
lar junctions of nerve cells overexpressing Munc13-1WT
(as identified by GFP fluorescence), we observed a
strong increase in the responsiveness of synapses to
phorbol esters. In the example illustrated in Figure 7B,
local application of 200 nM 4b-TPA increased the aver-
age EPSC amplitude by 95% (7.7 6 1.4 nA to 15 6 3.1
nA; mean 6 s.d.). Following a fast initial rise within the
first 10 sec after 4b-TPA application, the amplitude
reached a plateau after approximately 60 sec. Analysis
of 13 Munc13-1WT-injected cells demonstrated an aver-
age increase of 82.1 6 12.9% (mean 6 s.e.m.) in relative
synaptic transmission following 4b-TPA application,
compared to about 45% in control cells that did not
express Munc13-1. This difference was statistically sig-
nificant as determined by t-test (p , 0.05).
To demonstrate that the observed increase in relative
synaptic transmission following Munc13-1WT expression
and phorbol ester stimulation is independent of PKC and
exclusively due to phorbol ester binding by Munc13-1, we
overexpressed Munc13-1H567K in Xenopus embryos and
analyzed synaptic transmission in the resulting neuro-
muscular junctions in culture. The His-567 to Lys muta-
tion in Munc13-1H567K abolishes phorbol ester binding
to the Munc13-1 C1-domain and prevents its phorbol
ester±induced translocation to the plasma membrane
(Figures 4, 5, and 6). Likewise, phorbol ester stimulation
of synaptic transmission in neuromuscular junctions
overexpressing Munc13-1H567K was indistinguishable from
that of uninjected controlsynapses (Figure 7C), although
expression levels of Munc13-1H567K were identical to
those obtained for Munc13-1WT (data not shown). Ap-
plication of 200 nM 4b-TPA resulted in an average
increase in relative transmitter release of 50% (Figure
7C), which was almost identical to that observed in
control cells. Analysis of 11 Munc13-1H567K-injected cells
demonstrated an average increase of 42.1 6 5.1%
(mean 6 s.e.m.) in relative synaptic transmission follow-
ing 4b-TPA application, compared to about 45% in con-
trol cells that did not express Munc13-1 and 82.1 6
12.9% in cellsexpressing Munc13-1WT (Figure 7D). These
data suggest that activation of the Munc13-1 C1-domain
Figure 4. Phorbol Ester Binding to the Munc13-1 C1-Domain by phorbol esters enhances neurotransmitter release.
(A) Bindingof 3[H]4b-PDBu towild-type Munc13-1 C1-domain (Munc13- We further characterized the shape and amplitudes
1C1WT) and mutated Munc13-1 C1-domain(Munc13-1C1H567K). Proteins
of EPSCs recorded before 4b-TPA application fromwere used as GST fusion constructs. Binding of GST alone served
as a negative control. Data are given as mean of double determina- Munc13-1- and Munc13-1H567K-injected neurons and com-
tions (bar indicates range). Specific binding of 3[H]4b-PDBu to the pared them to those of uninjected control cells. As ex-
Munc13-1 C1-domain is abolished by the His-567 to Lys mutation. emplified in the EPSC traces in Figures 7A, 7B, and 7C,(B) Saturation binding of 3[H]4b-PDBu to wild-type Munc13-1
there was no significant change in the overall shape ofC1-domain (GST fusion construct).
(C) Scatchard analysis of saturation binding of 3[H]4b-PDBu to wild- the EPSCs following Munc13-1 mRNA injection. Like-
type Munc13-1 C1-domain (GST fusion construct). wise, comparison of EPSC rise times and half-widths did(D) Inhibition of 3[H]4b-PDBu binding to wild-type Munc13-1
not reveal any significant differences between control,C1-domain by diacylglycerol (GST fusion construct).
(E) Inhibition of 3[H]4b-PDBu binding to wild-type Munc13-1 Munc13-1- and Munc13-1H567K-expressing neurons (data
C1-domain (GST fusion construct) by PKC ligands. a and b phorbol not shown). Table 1 summarizes the effects of Munc13-1
esters (PDBu and TPA), 1 mM; calphostin C, 20 mM; polymyxin B,
and Munc13-1H567K expression on basal synaptic trans-17.5 mM; bisindolylmaleimide (BIS), 3 mM.
Data are given as mean (B and C) or mean 6 s.e.m. (A, D, and E) mission. While there was no difference in the degree of
of double (A) or triple (B-E) determinations. Note that all ligands paired pulse facilitation (which may serve as a measure
of PKC C1-domains inhibit phorbol ester binding to the Munc13-1 for differences in release probability), the absolute EPSCC1-domain, while the inactive a phorbol esters and bisindolylmalei-
mide (BIS, binds to the ATP binding site of PKC) do not. amplitudes were somewhat larger, and coefficients of
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Figure 5. Phorbol Ester-Induced Transloca-
tion of Munc13 Isoforms
HEK293 cells were transfected with expres-
sion vectors encoding full-length Munc13-1,
-2, and -3, as well as full-length Munc13-1H567K
(His-567 to Lys mutation in the C1-domain,
abolishing phorbol ester binding) with C-ter-
minally attached GFP. Cells were either incu-
bated in the presence of 100 nM 4b-TPA or
kept under control conditions (no TPA), and
the subcellular localization of expressed pro-
teins was analyzed with a BioRad MRC 1024
confocal laser scanning microscope. Note
that all wild-type Munc13 isoforms translo-
cate to the plasma membrane in response
to phorbol ester, whereas the phorbol ester
insensitive full-length mutant Munc13-1H567K
does not.
variation (which reflect the variability of EPSC ampli- of 1±3 sec immediately after the end of the last EPSC
in a six pulse train and compared their frequency andtudes) were slightly smaller in Munc13-1- and Munc13-
1H567K-expressing neurons as compared to control cells. amplitudes. Figure 8 depicts examples of SSCs col-
lected immediately after the train in the absence or pres-These differences in basal synaptic transmission may
indicate an increased quantal content in overexpressing ence of 4b-TPA. The average frequency for control cells
was 1.6 Hz before 4b-TPA application and increased tocells (Table 1).However, thesignificance of this observa-
tion needs to be reexamined in a different experimental 2.4 Hz after 4b-TPA application (Figures 8A and 8B).
Munc13-1-injected cells exhibited an average SSCparadigm because an unequivocal interpretation of
quantitative data is difficult in the Xenopus system that frequency of 3.8 Hz before 4b-TPA treatment, approxi-
mately 2.5 times higher than that of control cells. Follow-is characterized by a rather high variability of absolute
ampitudes between cells/preparations. ing 4b-TPA application, the frequency increased to 7.2
Hz in Munc13-1-injected cells (Figures 8A and 8B). InAn EPSC is often followed by a phase of asynchronous
release that most likely reflects the increased release contrast, the SSC frequency in cells expressing the mu-
tant Munc13-1H567K was not significantly elevated (Fig-probability of single vesicles due to elevated calcium
(Rahamimoff and Yaari, 1973). We recorded these as ures 8A and 8B). Average SSC amplitudes were slightly
smaller in Munc13-1- and Munc13-1H567K-expressing cellsªspontaneous synaptic currentsº (SSCs) for a duration
Role of Munc13-1 in Transmitter Release
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Figure 6. Phorbol Ester-Induced Transloca-
tion of Munc13-1 Is Mediated by the C1-
domain
HEK293 cells were transfected with expres-
sion vectors encoding fragments of Munc13-1
tagged with GFP. Cells were either incubated
in the presence of 100 nM 4b-TPA or kept
under control conditions (no TPA), and the
subcellular localization of expressedproteins
was analyzed with a BioRad MRC 1024 con-
focal laser scanning microscope. Munc13-
1C1, Munc13-1 C1-domain; Munc13-1C1/C2,
Munc13-1 C1C2-tandem domain; Munc13-
1C1/C2H567K, Munc13-1 C1C2-tandem domain
with His-567 to Lys mutation (abolishing
phorbol ester binding). See Experimental
Procedures for residues covered by these
clones, and Figure 3 for their representation
in the Munc13-1 domain structure. Note that
the Munc13-1 C1-domain is sufficient to me-
diate translocation in response to phorbol
ester.
as compared to control cultures (Table 1). These results present study, we provide direct evidence for an involve-
ment of Munc13 proteins in presynaptic function.indicate that Munc13-1 also enhances the asynchro-
nous release of synaptic vesicles by a mechanism that
is largely dependent on the presence of an intact Munc13-1 Is a Presynaptic Protein
C1-domain. Previous attempts to determine the precise localization
of Munc13 proteins failed due to the poor specificity of
the available antibodies in immunocytochemistry (BroseDiscussion
et al., 1995; Betz et al., 1997). For that reason, we gen-
erated a new isoform-specific monoclonal antibody toSeveral indirect lines of evidence have identified Munc13
proteins as possible regulators of synaptic transmission: Munc13-1 (see Experimental Procedures) that was used
to demonstrate an almost exclusively presynaptic lo-(1) Mutations in their C. elegans counterpart unc-13p
lead to a paralyzed phenotype characterized by accu- calization of Munc13-1 (Figures 1 and 2). Our findings
demonstrate that a first prerequisite supporting pub-mulation of neurotransmitter and resistance to acetyl-
choline esterase inhibitors, suggesting a deficit in trans- lished conjectural claims of a presynaptic function of
Munc13-1 and unc-13p, namely its appropriate localiza-mitter release in these mutants (Hosono et al., 1987;
Hosono and Kamiya, 1991); (2) the primary structures tion, is indeed met.
Munc13-1 appears to be concentrated at synapticof Munc13 and unc-13 proteins contain C1- and C2-
domains, indicating a regulation of Munc13/unc-13p active zones. In the large hippocampal mossy fiber ter-
minals, Munc13-1 immunoreactivity was most promi-function by diacylglycerol and calcium (Maruyama and
Brenner, 1991; Ahmed et al., 1992; Kazanietz et al., nent in presynaptic subcompartments that were op-
posite of postsynaptic densities (Figure 1). Given the1995); (3) Munc13-1 interacts with syntaxin 1, a compo-
nent of the synaptic release machinery involved in syn- limited diffusibility of the dye reaction product generated
with our immunodetection method, these data suggestaptic vesicle priming and fusion (Betz et al., 1997); and
(4) Munc13-1 interacts with DOC2, a putative regulator that Munc13-1 is concentrated at presynaptic release
sites and not distributed uniformly in the presynapticof transmitter release, and influences DOC2-stimulated
exocytosis from PC12 cells (Orita et al., 1997). In the cytosol. Support for this view is provided by biochemical
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observed in parietal cortex (55% of all observed termi-
nals) and, to a lesser extent, in the stratum radiatum of
the hippocamus (44% of all observed terminals). These
percentages represent maximum values because lim-
ited antibody penetration contributes significantly to the
number of unstained structures. However, our observa-
tions indicate that a significant number of synapses in
cortex and hippocampus do not contain Munc13-1. We
assume that these synapses contain Munc13-2 as in
situ hybridization data demonstrate (I. A. and N. B., un-
published data) that Munc13-1 and Munc13-2 but not
Munc13-3 are coexpressed in cortex and hippocampus
of the rat.
The only exception to the presynaptic localization of
Munc13-1 was observed in cerebral cortex. Here, about
10% of all Munc13-1-positive structures were localized
in dendrites. In most cases, the Munc13-1 immunore-
activity was confined to the vicinity of vesicular struc-
tures (Figure 2D). It is possible that these postsynaptic
Munc13-1-containing structures represent dendritic re-
lease sites (Piotte et al., 1985; Chazal and Ohara, 1986;
Pucak and Grace, 1994).
Munc13 Proteins Are Phorbol Ester Receptors
The C1-domains of the three known Munc13 isoforms are
extremely homologous and contain all critical residues
necessary for phorbol ester binding in PKCs (Kazanietz
et al., 1994). Of the 51 residues that comprise the core
Cys6His2 motif of the C1-domain zinc finger, only two
are different between the isoforms: Munc13-1 Ile-590 is
replaced by Leu in Munc13-2 and Munc13-1 Thr-598 isFigure 7. Phorbol Ester-Mediated Increase of Evoked Postsynaptic
replaced by Ser in Munc13-2 and by Leu in Munc13-3Currents Is Enhanced in Munc13-1-Injected Neuromuscular Junc-
tions (Betz et al., 1996). Because of this high homology, we
(A±C) Neuromuscular cocultures from control embryos (A), from assumed the biochemical characteristics of the three
embryos injected with wild-type Munc13-1 mRNA (B), and from C1-domains to be similar. We selected the C1-domain
embryos injected with mRNA encoding Munc13-1H567K (C) were ana- of Munc13-1, the most abundant isoform (Brose et al.,
lyzed as described. (Left) Normalized EPSC amplitudes from a con-
1995), for a detailed analysis of phorbol ester binding.trol (A), Munc13-1-injected (B), and Munc13-1H567K-injected (C) neu-
Our binding data are in agreement with and extendron before and after application of 200 nM 4b-TPA (arrow). Each
previous studies on unc-13p (Maruyama and Brenner,data point (filled circle) represents the first EPSC amplitude out of
a train of six or two stimuli given (see Experimental Procedures). 1991; Ahmed et al., 1992; Kazanietz et al., 1995). We
(Right) An average EPSC (10 responses) before and after 4b-TPA demonstrate that phorbol ester binding to the Munc13-1
application is shown on the right. The shapes of the EPSCs were C1-domain isvirtually indistinguishable from that observednot changed significantly. Scale bars, 5 msec; 4 nA.
in PKCs. The phorbol ester affinity of the Munc13-1 C1-(D) Relative increase in synaptic transmission in control neurons
domain (KD 5 5 nM; Figures 4B and 4C) is very similarand in neurons injected with Munc13-1 or Munc13-1H567K mRNA. The
to that of intact PKCs (KD 5 2.6 nM for PKCg) and ofaverage increase in synaptic transmission following 200 nM 4b-TPA
was 44.6 6 4.8% in control cells (mean 6 s.e.m.; n519), 82.1 6 isolated PKC C1-domains (KD 5 3.4 nM for PKCg C1-
12.9% in Munc13-1-injected neurons (mean 6 s.e.m.; n513), and domain) (Quest and Bell, 1994). Furthermore, the struc-
42.1 6 5.1% (mean 6 s.e.m.; n511) in Munc13-1H567K-injected neu- tural requirements for phorbol ester binding appear to
rons. The increase in transmission in Munc13-1-injected neurons
be the same in Munc13-1 and PKC C1-domains. Like inwas significantly higher than that observed in control and Munc13-
PKC (Quest et al., 1994), mutation of the first His residue1H567K-injected cells (t-test, p , 0.05). The inactive phorbol ester
in the Cys6His2 motif of Munc13-1 (His-567 to Lys) abol-4a-PDBu was inactive in all cells tested (data not shown).
ishes binding completely (Figures 3B and 4A), demon-
strating that the integrity of the C1-domain zinc finger is
essential for phorbol ester binding.analyses that demonstrated that Munc13-1 is largely
insoluble, most likely associated with components of In addition, the pharmacological characteristics of
phorbol ester binding to Munc13-1 closely resemble thethe synaptic cytoskeleton, but not present on synaptic
vesicles (Brose et al., 1995; Betz et al., 1997). However, inhibitor profile described for PKC C1-domains (Gordge
and Ryves, 1994). Most importantly, diacylglycerol, anan unequivocal determination of Munc13-1 localization
within the presynaptic terminal can only be achieved endogenous ligand for PKC C1-domains, inhibits binding
to the Munc13-1 C1-domain with a potency comparablewith preembedding immunogold methods, which have
so far been unsuccessful with our antibody. to that observed in PKC (Sharkey et al., 1984). Also,
calphostin C, the most potent and most frequently usedMultiple Munc13-1-negative presynaptic terminalswere
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Table 1. Basal Transmitter Release Characteristics in Munc13-1- and Munc13-1H567K-Overexpressing Cultures before Phorbol Ester
Treatment
Control Munc13-1 Munc13-1H567K
EPSC amplitudes (nA) 3.94 6 0.54 (37) 5.26 6 0.71 (22) 6.7 6 1.08 (15)
Coefficient of variation 0.36 6 0.03 (37) 0.29 6 0.03 (22) 0.287 6 0.02 (15)
Paired pulse facilitation ratio 0.92 6 0.03 (37) 0.90 6 0.03 (22) 0.93 6 0.03 (15)
SSC amplitudes (nA) 0.46 6 0.06 (23) 0.36 6 0.03 (12) 0.41 6 0.08 (6)
SSC frequency (Hz) 1.6 6 0.34 (23) 3.8 6 0.64 (12) 2.3 6 0.7 (6)
Quantal content (I/q) 8.5 14.6 16.3
Quantal content (1/CV2) 7.7 11.8 12.1
Data are presented for control, Munc13-1-, and Munc13-1H567K-overexpressing cells. I, mean EPSC amplitude; q, mean SSC amplitude; CV,
coefficient of variation. Errors are given as standard error of the mean (s.e.m.); numbers in parentheses indicate the number of experiments.
C1-domain antagonist, and the typically used PKC-acti- (Figures 5 and 6). This effect is abolished in a Munc13-1
mutant that is unable to bind phorbol ester (Munc13-vating 4b phorbol esters, inhibit binding (Figure 4E). In
contrast, 4a phorbol esters (Figure 4E), which are often 1H567K;Figures 5 and 6). It can therefore not be dependent
on PKC or a neuron-specific binding partner but mustapplied as inactive control reagents in PKC experiments,
and C2-ceramide, a possible endogenous ligand of C1- occur in response to a direct action of phorbol esters
on the Munc13 C1-domain. In certain PKC and synapto-domains (data not shown), do not bind to the Munc13-1
C1-domain. tagmin isoforms, membrane translocation or membrane
binding can also be mediated by Ca21/phospholipidThese observations establish Munc13 proteins as
novel phorbol ester targets whose most likely endoge- binding to the regulatory C2-domains (Brose et al., 1992;
Davletov and SuÈdhof, 1993; Newton, 1995, 1997; Sakainous ligand is diacylglycerol. Our data imply that among
the typically used control reagents in phorbol ester ex- et al., 1997). However, increasing the intracellular Ca21
concentration by addition of a Ca21 ionophore did notperiments on PKC (C1-domain antagonists like calphos-
tin C, inactive 4a phorbol esters, inhibitors of ATP bind- induce membrane translocation of full-length Munc13
isoforms or of Munc13-1 fragments containing the cen-ing like bisindolylmaleimide), only potent and selective
inhibitors of ATP binding to PKC would allow one to tral C2-domain (data not shown).
These data strongly suggest that ligand binding to thedistinguish phorbol ester±mediated effects on PKC from
those on Munc13 proteins (assuming that Munc13s do Munc13 C1-domains has direct structural and functional
consequences in a cellular environment. They result innot bind these ligands with a binding site outside the
C1-domain). In the past, a large number of studies in- a subcellular redistribution and membrane association
of Munc13 proteins that may regulate an as yet unidenti-vestigating phorbol ester±mediated effects on PKC used
control conditions that are inadequate in the light of the fied enzymatic activity. In contrast, Munc13 C2-domains
may not function in Ca21/phospholipid signaling andpresent findings (i.e., C1-domain antagonists or inactive
4a phorbol esters; see Gordge and Ryves, 1994, for a Ca21-dependent membrane association.
Translocation of Munc13 isoforms in the synapse isrecent review). Given the fact that ubiquitous Munc13
isoforms exist (GenBank entry AF020202; I. A., A. B., likely to be modulated by additional mechanisms. In rat
brain, Munc13-1 and 23 are largely insoluble (Brose etand N. B., unpublished data), conclusions drawn from
those studies would have to be reevaluated for a possi- al., 1995; I. A., A. B., and N. B., unpublished data).
Munc13-1 is specifically targeted to presynaptic ac-ble involvement of Munc13 proteins if direct, PKC-inde-
pendent effects of phorbol esters on these novel targets tive zones (Figures 1 and 2) by an unknown mechanism
that may involve cytoskeletal components (Brose et al.,were demonstrated.
1995, unpublished data). Consequently, a diacylglycerol-
dependent membrane association/dissociation cyclePhorbol Ester-Mediated Regulation of Munc13
Proteins Is Direct and Independent of PKC of Munc13-1 must take place in the microenvironment
of the presynaptic release site. In contrast, rat brainMembrane translocation of PKCs in response to phorbol
esters is a well established phenomenon (Newton, 1995, Munc13-2 is mostly soluble (I. A., A. B., and N. B., unpub-
lished data), and translocation in response to diacylglyc-1997; Sakai et al., 1997). Phorbol esters bind to the C1-
domain of PKCs and serve as hydrophobic anchors that erol is likely to produce more profound changes in the
overall distribution of the protein.recruit the enzyme to the plasma membrane, stabilize
its active conformation, and increase its susceptibility
to other second messengers (Newton, 1995, 1997). In Munc13-1 Is a Phorbol Ester-Dependent
Enhancer of Transmitter Releaseorder to investigate whether phorbol ester binding to
Munc13 isoforms indeed has structural and functional Our morphological, biochemical, and cell biological ob-
servations (Figures1±6) suggest a role for Munc13-1 as aconsequences for these proteins, we studied the effects
of phorbol ester treatment on the subcellular distribution second messenger-dependent regulator of presynaptic
function. To determine if Munc13-1 alters neurotransmitterof Munc13-1, -2, and -3 isoforms that were C-terminally
tagged with GFP. secretion in response to phorbol esters, we overex-
pressed full-length Munc13-1WT and the phorbol ester±All three Munc13 isoforms, as well as the isolated
Munc13-1 C1-domain, translocate to the plasma mem- insensitive mutant Munc13-1H567K in Xenopus neuromus-
cular cocultures and analyzed the electrophysiologicalbrane of HEK293 cells in response to phorbol esters
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has several advantages over other experimental para-
digms. Proteins are expressed by the endogenous Xe-
nopus protein synthesis machinery following injection
of the respective mRNAs. This allows the expression
of very large proteins, such as Munc13-1, which could
otherwise not be synthesized in amounts sufficient for
protein injection or that are too large for diffusion-based
application through a patch pipette. Furthermore, gener-
ation and analysis of mutations are simple because se-
quence manipulations are performed on the cDNA level.
Clearly defined mRNA constructs and their mutants can
be introduced, allowing the design of optimal control
conditions (point mutations, etc.). Finally, deleterious
effects that may be associated with direct injections
of peptides or proteins into presynaptic terminals are
circumvented. The major disadvantage of the Xenopus
neuromuscular coculture system is the fact that re-
corded responses can vary by a factor of 20 (0.5±10
nA, depending on the preparation/synapse examined),
making a reliable quantitativeanalysis of absolute ampli-
tude values almost impossible. We therefore concen-
trated in our analysis of Munc13-1 and Munc13-1H567K
overexpression on the relative effects of phorbol esters
on transmitter release. Xenopus neuromuscular cocul-
tures were used in the past to overexpress synapsin IIa
(Schaeffer et al., 1994), synaptophysin (Alder et al., 1995),
and frequenin (Olafsson et al., 1995).
When Munc13-1WT mRNA is injected into Xenopus
embryos, the resulting neuromuscular synapses show
a higher susceptibility to phorbol esters than untreated
junctions (Figure 7). This gain-of-function effect of
Munc13-1WT is specific for the overexpressed protein,
dependent on an intact C1-domain, and independent of
PKC, as it is not observed when the phorbol ester±
insensitive mutant Munc13-1H567K is expressed at com-
parable levels (Figure 7).
A similar C1-domain-dependent activity of Munc13-1
is also apparent on the level of SSCs following trains ofFigure 8. Overexpression of Munc13-1 Enhances the Frequency of
Asynchronous Neurotransmitter Release in Xenopus Neuromuscu- stimuli. Here, Munc13-1WT expression leads to an in-
lar Junctions crease in the frequency of SSCs even in the absence of
(A) Representative traces of asynchronous release activity (SSCs) external phorbol esters. This effect is augmented when
recorded from muscle cells that were innervated either by a control 4b-TPA is applied. In contrast, expression of the phorbol
neuron (upper), a Munc13-1-overexpressing neuron (middle) or a ester±insensitive mutant Munc13-1H567K does not signifi-
Munc13-1H567K-overexpressing neuron (lower). The left traces were
cantly affect SSC frequencies when compared to unin-recorded before and the right traces after 4b-TPA application (200
jected control cells (Figure 8).nM). The currents on the muscle cellare shown as downward deflec-
These data indicate that Munc13-1 is a functional reg-tions and represent single SSCs. Scale bars, 0.2 sec; 0.4 nA.
(B) Summary of SSC frequency in control neurons, Munc13-1-over- ulator of synaptic efficacy. Phorbol ester binding to the
expressing neurons, and Munc13-1H567K-overexpressing neuronsbe- Munc13-1 C1-domain or binding of residual membrane
fore (left) and after 4b-TPA application (200 nM, right). The average diacylglycerol in the case of synapses that were not
SSC frequency for control cells was 1.6 Hz before and 2.4 Hz after
treated with 4b-TPA appears to activate the protein,4b-TPA application. For Munc13-1-overexpressing neurons, the av-
which in turn enhances transmitter release.erage frequencies were 3.8 and 7.2 Hz before and after 4b-TPA
In addition to this, both Munc13-1 and Munc13-1H567Kapplication, and for Munc13-1H567K-overexpressing neurons the aver-
age frequencies were 2.4 and 4.2 Hz before and after 4b-TPA appli- overexpression lead to moderate increases in EPSC am-
cation. Data are given as mean 6 s.e.m. of 23 (Control), 12 (Munc13- plitudes and quantal content, indicating stimulatory ef-
1) or 6 (Munc13-1H567K) experiments. Differences in SSC frequencies fects of Munc13-1 on transmitter release that are inde-
between control and Munc13-1-overexpressing cells were statisti-
pendent of the intact C1-domain. However, to verifycally significant (t-test, p , 0.05).
these findings, a detailed study of the role of Munc13-1
in basal synaptic release has to be performed in a differ-
characteristics of overexpressing synapses after phor- ent experimental paradigm.
bol ester treatment. In principle, the observed changes in synaptic trans-
With respect to the question addressed in the present mission due to Munc13-1 overexpression can be ex-
plained by (1) an effect of the protein on the structurestudy, the Xenopus heterologous expression system
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NaCl, and 0.5% ZnCl2. Thereafter, the animals were again perfusedof synapses (e.g., the number of release sites per syn-
with 0.9% NaCl for 7 min to limit effects of postfixation. Brains wereapse), or by (2) an increased release-ready vesicle pool
immediately dissected and cryoprotected with 30% sucrose. On aafter Munc13-1 expression,or by (3) an effect of Munc13-1
frozen microtome, 40 mm thick sections were cut for light and elec-
on the release probability. Our data do not allow us to tron microcopic immunocytochemistry. The methods employed
determine unequivocally the level at which Munc13-1 have been previously detailed (Rickmann and Wolff, 1995). In brief,
after blocking unspecific antibody binding, anti-Munc13-1 mono-acts in the synaptic vesicle cycle. The fact that Munc13-1
clonal antibodies (clone 3H5) in ascites fluid were diluted 1:250 andoverexpression does not alter paired pulse facilitation
applied for 12±16 hr at 378C. These were detected with the ABCor the coefficient of variation suggests that the protein
method (Vector Laboratories) followed by a histochemical nickel-
does not affect release probability (Table 1). Given its intensified horseradish peroxidase reaction with 3,39-diaminobenzi-
subcellular localization and biochemical characteristics, dine. For electron microscopy, sections were osmicated and flat
Munc13-1 is most likely to act on the release-ready embedded. Only well reacted tissue (close to the surface of the
incubated frozen sections) selected during double resectioning wasvesicle pool at the level of the active zone. Munc13-1
used for the present investigation.interacts directly with the exocytotic core complex by
When a monoclonal antibody is used for immunostaining, the mainbinding to syntaxin (Betz et al., 1997), with DOC2 (Orita sources of crossreactivity or artefactual staining are nonspecific
et al., 1997), and with components of the cytoskeleton antibodies and contaminating proteins in the ascites fluid.Therefore,
(Brose et al., 1995, unpublished data). It is possible that control experiments were performed with (1) anti-Munc13-1 mono-
clonal antibody ascites fluid that had previously been preadsorbedthese interactors recruit Munc13-1 to docked vesicles
to a Sepharose column coupled with the antigen used to generateat the active zone. There, itwould be activated by diacyl-
the antibody and (2) secondary antibody alone. Under both condi-glycerol in the plasma membrane either to promote vesi-
tions, staining of brain sections was completely abolished (data not
cle docking or to perform a priming role, e.g., by altering shown). To exclude the possibility that our nonstandard fixation
the fusogeneity of the presynaptic plasma membrane scheme gave rise to nonspecific staining, we performed additional
or by affecting the stability of the core complex. To control experiments with antibodies directed against GFAP. The
resulting (predicted) glial labeling pattern was clearly different fromidentify the locus of Munc13-1 action, the exact molecu-
the staining observed with the anti-Munc13-1 monoclonal antibodylar or enzymatic function of Munc13-1 will have to be
(data not shown), further demonstrating the specificity of our stain-elucidated.
ing protocol.
Expression of Recombinant ProteinsConclusion
Bacterial expression vectors encoding GST in frame with theMunc13-1 is a high-affinity phorbol ester and diacylglyc-
Munc13-1 C1-domain (Munc13-1C1WT and Munc13-1C1H567K; residueserol receptor localized in the presynaptic terminal. It
556±651 of GenBank Acc. No. U24070) were generated in pGEX-represents a novel, PKC-independent target of the diac-
KG using PCR fragments (Figure 3). Proteins were expressed and
ylglycerol second messenger pathway. Activation of purified as described (Guan and Dixon, 1991). The mutation His-
Munc13-1 by phorbol esters induces its membrane as- 567 to Lys was generated by PCR, using primers that carried the
appropriate coding sequence substitution (CAC to AAG at positionsociation and enhances transmitter release. Munc13
2807±2809 of the Munc13-1 cDNA).proteins may be responsible for a number of phorbol
Mammalian expression vectors encoding full-length Munc13-1WT,ester effects on synaptic transmission and membrane
Munc13-2, Munc13-3, and Munc13-1H567K with a green fluorescent
traffic that cannot be attributed to PKC (Scholfield and protein (GFP) sequence attached at their C termini were constructed
Smith, 1989; Fabbri et al., 1994; Redman et al., 1997). in pEGFP-N1 (Clontech) using a combination of previously published
The presence of Munc13-1 as a functional diacylglycerol cDNA fragments (Brose et al., 1995; GenBank Acc. No. U24070,
U24071, and U24072) and engineered PCR fragments that ensuredand phorbol ester target at the active zone of the pre-
reading frame conservation (Figure 3). Constructs encoding thesynaptic terminal allows direct access for diacylgly-
Munc13-1 C1/C2 tandem domain with a GFP sequence attached atcerol second messengers to the transmitter release ma- its C terminus (Munc13-1C1/C2WT and Munc13-1C1/C2H567K; residues
chinery, thereby adding a novel regulatory process to 556±826) were generated in pcDNA3-GFP (pcDNA3 from Invitrogen
our understanding of synaptic transmission. Ubiquitous with EGFP insert) using PCR fragments that carried engineered
Kozak consensus sequences and starter ATGs at the 59 ends (FigureMunc13 isoforms may exert related functions in other
3). The construct encoding the Munc13-1 C1-domain with antissues and cell types.
N-terminally attached GFP sequence (Munc13-1C1; residues 522±
651 allowing a larger distance between GFP and the C1-domain) wasExperimental Procedures generated in pEGFP-C2 (Invitrogen) using a PCRfragment (Figure 3).
The His-567 to Lys mutations were introduced by PCR (see above).
Generation of Monoclonal Antibodies to Munc13-1 Munc13-1 vectors for use in Xenopus embryo expression experi-
A monoclonal antibody to Munc13-1 was generated in collaboration ments (Munc13-1WT and Munc13-1H567K) were generated in pCS21
with BioGenes (Berlin) using a fusion protein antigen encoding GST (Rupp et al., 1994) using inserts from a previously published full-
in frame with residues 1399±1736 of Munc13-1 (pGEX-Munc13-1F; length Munc13-1 cDNA (Brose et al., 1995). The His-567 to Lys
Betz et al., 1997). The monoclonal antibody (clone 3H5) detects a mutation was generated by replacement of part of the wild-type
single band of 200 kDa in Western blots of brain membranes and sequence with a mutated cDNA fragment.
HEK293 cells transfected with pcDNA-Munc13-1 (Brose et al., 1995), All PCR-based constructs were verified by dideoxy chain termina-
which expresses full-length Munc13-1 (data not shown). tion sequencing with dye terminators on an Applied Biosystems 373
DNA sequencer (Applied Biosystems). HEK293 cells were trans-
Immunocytochemistry fected with the above constructs using the calcium phosphate co-
Adult, female Sprague-Dawley rats were anesthetized with ether precipitation method (Chen and Okayama, 1987).
and fixed by transcardial perfusion. Due to the sensitivity of the
antigen recognized by the anti-Munc13-1 monoclonal antibody Phorbol Ester Binding Assays
(clone 3H5), a nonstandard fixation scheme was applied. After flush- Binding of [3H]phorbol-12,13-dibutyrate ([3H]4b-PDBu, 16 Ci/mmol;
ing the vascular system with 0.9% NaCl (ca. 3 min), a fixative was Amersham) to recombinant glutathione-S-transferase fusion pro-
teins was measured according to Sharkey and Blumberg (1985).perfused for 7 min that consisted of 4% unbuffered formalin, 0.9%
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[3H]4b-PDBu (10 nM) was incorporated into liposomes (20% phos- (Laemmli, 1970; Towbin et al., 1979; Brose et al., 1993), and immuno-
reactive bands were visualized by enhanced chemoluminescencephatidylserine, 80% phosphatidylcholine, 300mg/ml final concentra-
(ECL; Amersham).tion in assay; Avanti Polar Lipids) before addition to the assay.
Both Munc13-1 andMunc13-1H567K were readily detectable at simi-For that purpose, chloroform solutions of phosphatidylserine and
lar levels in 2- and 3-day-old embryos (data not shown), indicatingphosphatidylcholine were evaporated under a stream of nitrogen.
the presence of the proteins at times when electrophysiologicalDried lipids were resuspended in 50 mM Tris-HCl (pH 7.4) and 1
measurements were performed. Likewise, GFP fluorescence wasmM EGTA and sonicated for 40 sec with a Braun Labsonic U tip
detected for several days after injection. As expected, noninjectedsonicator (Braun). Liposomes were centrifuged for 45 min at 3000 3
embryos showed no rat Munc13-1 immunoreactivity.gmax to remove aggregates and kept on ice until use. Nonspecific
binding was determined in the presence of 30 mM unlabeled 4b-
Electrophysiological Recordings and Data AnalysisPDBu (Sigma). Saturation binding was assayed in the presence of
Prior to recording, spinal neurons were examined for GFP fluores-increasing concentrations of [3H]4b-PDBu (1±50 nM). Competition
cence. A monochromator-based illumination system (T.I.L.L. Pho-assays with diacylglycerol were carried out in the presence of in-
tonics) was coupled into the epifluorescence port of an inverted IMcreasing concentrations of 1,2-dioctanoyl glycerol (Avanti Polar
35 microscope (Zeiss) using a Fluar objective (403, 1.3 N. A., oilLipids). Competition assays with 4b-12-O-tetradecanoylphorbol-13-
immersion; Zeiss). Excitation wavelength for GFP was 488 nm, andacetate (4b-TPA; Sigma), 4a-PDBu (Biomol), 4a-TPA (Biomol),
the filter set was DC495, LP505 (T.I.L.L. Photonics).Calphostin C (Calbiochem; light activated according to Fabbri et
GFP-containing fluorescent nerve cells were assumed to coex-al., 1994), polymyxin B (Sigma), and bisindolylmaleimide (Sigma)
press Munc13-1 or Munc13-1H567K, respectively. Synaptic currentswere performed using the same procedure. Dependingon the exper-
were recorded from innervated musclecells in the whole-cell config-iment, 0.3±3 mg protein were used per assay. Each data point repre-
uration using a combination of EPC-9 and EPC-7 amplifiers drivensents the average of duplicate ([3H]4b-PDBu binding to wild-type
by the Pulse v8.06 software package (Heka Elektronik). The pipetteand mutated C1-domain) or triplicate (other experiments) determina- solution for the muscle cells contained 107 mM CsCl, 1 mM MgCl2,tions. Each experiment was performed at least twice with essentially
1 mM NaCl, 10 mM EGTA, and 10 mM HEPES (pH 7.3). The bath
identical results.
solution contained normal frog ringer (NFR, 116 mM NaCl, 2 mM
KCl, 1 mM MgCl2, 1.8 mM CaCl2, and 5 mM HEPES [pH 7.3]). The
muscle cells were routinely clamped at 250 mV holding potential.Translocation Assays
A 10 ms test pulse to 260 mV was given before each EPSC sweepHEK293 cells were grown on glass coverslips coated with 0.5%
to estimate the series resistance for later offline series resistancegelatine (Schnittler et al., 1993) and transfected with GFP expression
compensation as previously described (Rettig et al., 1997). Actionvectors 2 days prior to the experiment. The media was changed
potentials were routinely elicited upon external stimulation (0.3±0.5before the experiment, and 4b-TPA (Sigma) was added from an
ms, 0.2±2 mA) on the nerve cell soma with frequencies of 0.5 Hz.aceton stock solution directly to the cell culture (100 nM final con-
Alternatively, the whole-cell configuration was established on the
centration). Cells were incubated for 5±60 min at 378C, washed twice
soma of the nerve cell, and the nerve cell was held at a potential
with phosphate-buffered saline, and fixed with 3% paraformalde- between 250 and 270 mV in the current clamp mode. In current
hyde in phosphate-buffered saline. Cover slips were mounted onto clamp mode, trains of six action potentials with an interval of 25
slides with Fluoromount-G (Southern Biotechnology Associates) msec were elicited every 4 sec with 2 ms current injections of 900
and observed with a MRC 1024 confocal laser scanning microscope pA. The pipette was filled with 114 mM K-gluconate, 10 mM KCl, 1
(BioRad). mM NaCl, 1 mM MgCl2, 2 mM MgATP, 0.3 mM GTP, 50 mM fura-2,
and 10 mM HEPES (pH 7.3). Amplitudes of EPSCs were analyzed
with locally written software in IGOR (WaveMetrix, Inc.) as previouslyPreparation of Nerve-Muscle Cocultures
described (Rettig et al., 1997). No significant correlation was foundXenopus nerve-muscle cocultures were prepared from the neural
between the initial amplitude and the effect of 4b-TPA. Spontaneoustube and associated myotomal tissue of stage 20±22 embryos as
synaptic currents were recorded for a duration of 1±3 sec in experi-
described (Tabti and Poo, 1991; Rettig et al., 1997). Following disso-
ments that were performed in the current clamp mode. SSC ampli-
ciation in Ca21Mg21-free solution (125 mM NaCl, 2 mM KCl, 1.2 tudes and frequency were analyzed with locally written software in
mM EDTA, and 5 mM HEPES [pH 7.6]), cells were plated on glass IGOR (WaveMetrix, Inc.). The inactive phorbol ester 4a-PDBu did
coverslips pretreated for about 60 min with ECL (entactin, collagen not affect any of the cells tested (data not shown). Since we found
and laminin; Upstate Biotechnologies) and grown for about 24 hr at no apparent differences in either SSC frequency or phorbol ester
228C. The culture medium consisted of 70% Leibovitz L-15 supple- effect on EPSC amplitudes from Munc13-1-positive and Munc13-1-
mented with GMS-X, antibiotics (Life Technologies), and BDNF (Ala- negative muscle cells, the data were grouped regardless of whether
mone Labs). All electrophysiological experiments were carried out muscles cells were expressing Munc13-1 or Munc13-1H567K or no
1±2 days after plating. exogenous protein (as judged by GFP coexpression).
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